Related Experiment Video
Updated: Apr 18, 2026

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
Published on: March 3, 2023
House dust mite reduction and avoidance measures for treating eczema.
Helen Nankervis1, Emma V Pynn, Robert J Boyle
1Centre of Evidence Based Dermatology, The University of Nottingham, A103, King's Meadow Campus, Lenton Lane, Nottingham, UK, NG7 2NR.
House dust mite reduction measures show limited evidence for treating eczema. While some studies suggest modest benefits for those with specific allergies, more high-quality research is needed to confirm effectiveness.
Area of Science:
- Dermatology
- Allergology
- Environmental Health
Background:
- Eczema is a chronic, itchy inflammatory skin condition often exacerbated by environmental allergens.
- House dust mites are common triggers for allergic reactions, including worsening eczema symptoms in sensitive individuals.
Purpose of the Study:
- To evaluate the effectiveness of house dust mite reduction and avoidance strategies in managing eczema.
Main Methods:
- Systematic review of randomized controlled trials (RCTs) assessing interventions aimed at reducing house dust mite exposure.
- Searched multiple databases up to August 2014, including Cochrane, MEDLINE, and Embase.
- Included studies with participants of any age diagnosed with eczema, comparing various mite reduction methods against controls.
Main Results:
- Seven studies involving 324 participants were included, all with a high risk of bias.
- Inconsistent results were observed for clinician-assessed eczema severity; one study showed a modest benefit with a combined intervention.
- No clear evidence of difference was found for participant-assessed severity, topical treatment needs, or sensitivity to house dust mite allergen.
Conclusions:
- Current evidence is of very low quality, precluding definitive clinical practice recommendations.
- Modest benefits were observed in a subset of patients with atopic eczema sensitive to aeroallergens.
- High-quality, long-term trials focusing on single, easily implementable mite reduction measures are recommended.
More Related Videos
08:44Identification and Characterization of Immunogenic RNA Species in HDM Allergens that Modulate Eosinophilic Lung Inflammation
Published on: May 30, 2020
06:47Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment
Published on: September 27, 2017
Related Concept Videos
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma I: Introduction
Asthma-I: Introduction
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms: